SCHEMBL5861540

SCHEMBL5861540

O=C(O)C(=O)C(C(=O)O)c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.43
ACP3 P15309 1/20 0.43
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CXCL8 P10145 1/20 0.41
IGFBP3 P17936 1/20 0.38
IDO1 P14902 2/20 0.38
TDO2 P48775 2/20 0.38
IDO2 Q6ZQW0 2/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
ERCC5 P28715 1/20 0.37
FEN1 P39748 1/20 0.37
CASP1 P29466 1/20 0.36
CTSA P10619 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
FABP4 P15090 1/20 0.35
FABP5 Q01469 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244293 0.88 SRC (0.50) SRCACP3ALDH1A1MEN1KMT2A
Ethylene SCHEMBL8953448 0.84 SRC (0.46) SRCACP3ALDH1A1MEN1KMT2A
SCHEMBL8953446 0.82 SRC (0.45) SRCACP3ALDH1A1MEN1KMT2A
SCHEMBL8536416 0.81 SRC (0.43) SRCACP3ALDH1A1MEN1KMT2A
SCHEMBL8209137 0.81 CXCL8 (0.44) SRCACP3ALDH1A1MEN1KMT2A
SCHEMBL9577351 0.77 CXCL8 (0.47) ACP3ALDH1A1MEN1KMT2ACXCL8
SCHEMBL9518776 0.75 CXCL8 (0.47) ACP3ALDH1A1KMT2ACXCL8IDO1
Benzoic Acid SCHEMBL8953221 0.75 TSHR (0.47) SRCACP3ALDH1A1MEN1KMT2A
SCHEMBL5673859 0.74 ACP3 (0.47) ACP3ALDH1A1MEN1KMT2ACXCL8
SCHEMBL24733 0.74 LMNA (0.52) ACP3ALDH1A1MEN1KMT2ACXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7012146-B2 Ion channel modulating agents POSEIDON PHARMACEUTICALS A/S (DK) 2006-03-14 US disclosed
US-20020169203-A1 Ion channel modulating agents NEUROSEARCH A/S (DK) 2002-11-14 US disclosed
EP-1140784-A2 ION CHANNEL MODULATING AGENTS NEUROSEARCH A/S (DK) 2001-10-10 EP disclosed
WO-2000037422-A2 ION CHANNEL MODULATING AGENTS NEUROSEARCH A/S (DK) 2000-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169203-A1 Ion channel modulating agents KCNN3, KCNN1, KCNN2 SRC 1618/4885ACP3 3267/4885ALDH1A1 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.